T. Rowe Price — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

Avalyn Pharma Incavalynpharma.com inNASDAQ: AVLNSep 2023 · $175M

Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies.

BiotechHealthtech

Lyn Baranowski(CEO)in

Co-investorsAndera Partners Catalio Capital Management, LP F-Prime Capital InVivium Capital Norwest Venture Partners Pivotal Life Sciences +9 more

K2 Spacek2space.io in 𝕏Feb 2023

The page is an online gambling/betting operator ("OK9") targeting Vietnamese players, offering sports betting, online casino, slots, fish-shooting games, lottery, and card games.

Deep TechHardwareSpace TechWest Hollywood, US

Neeldev Kunjur(Executive Officer, Director)Karandev Kunjur(Executive Officer, Director)Karan Kunjur(Founder)inNeel Kunjur(Founder)in

Co-investorsAlpine Space Ventures Also Capital Asymmetric Capital Partners CapitalG Earthrise Ventures First Round Capital +22 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.